we evaluated 139 patients with superficial bladder cancer ( stages ta , tl , and tis ) and treated them with either intravesical bacillus calmette-guerin , tice strain ( bcg ) , or doxorubicin hydrochloride ( adriamycin [ adr ] ) in a nonrandomized , multicenter study .
C0546861
doxorubicin hydrochloride
C0085752
adriamycin